Cargando…
Exploring the microvascular impact of red blood cell transfusion in intensive care unit patients
BACKGROUND: Red blood cell (RBC) transfusion is a common treatment for hospitalized patients. However, the effects of RBC transfusion on microvascular function remain controversial. METHODS: In a medical ICU in a tertiary teaching hospital, we prospectively included anemic patients requiring RBC tra...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717366/ https://www.ncbi.nlm.nih.gov/pubmed/31470888 http://dx.doi.org/10.1186/s13054-019-2572-9 |
_version_ | 1783447543073472512 |
---|---|
author | Hariri, Geoffroy Bourcier, Simon Marjanovic, Zora Joffre, Jérémie Lemarié, Jérémie Lavillegrand, Jean-Rémi Charue, Dominique Duflot, Thomas Bigé, Naïke Baudel, Jean-Luc Maury, Eric Mohty, Mohamad Guidet, Bertrand Bellien, Jeremy Blanc-Brude, Olivier Ait-Oufella, Hafid |
author_facet | Hariri, Geoffroy Bourcier, Simon Marjanovic, Zora Joffre, Jérémie Lemarié, Jérémie Lavillegrand, Jean-Rémi Charue, Dominique Duflot, Thomas Bigé, Naïke Baudel, Jean-Luc Maury, Eric Mohty, Mohamad Guidet, Bertrand Bellien, Jeremy Blanc-Brude, Olivier Ait-Oufella, Hafid |
author_sort | Hariri, Geoffroy |
collection | PubMed |
description | BACKGROUND: Red blood cell (RBC) transfusion is a common treatment for hospitalized patients. However, the effects of RBC transfusion on microvascular function remain controversial. METHODS: In a medical ICU in a tertiary teaching hospital, we prospectively included anemic patients requiring RBC transfusion. Skin microvascular reactivity was measured before and 30 min after RBC transfusion. Plasma was collected to analyze intravascular hemolysis and draw the lipidomic and cytokine profiles. RESULTS: In a cohort of 59 patients, the median age was 66 [55–81] years and SAPS II was 38 [24–48]. After RBC transfusion, endothelium-dependent microvascular reactivity improved in 35 (59%) patients, but worsened in 24 others (41%). Comparing clinical and biological markers revealed that baseline blood leucokyte counts distinguished improving from worsening patients (10.3 [5.7; 19.7] vs. 4.6 [2.1; 7.3] × 10(9)/L; p = 0.001) and correlated with variations of microvascular reactivity (r = 0.36, p = 0.005). Blood platelet count was also higher in improving patients (200 [97; 280] vs 160 [40; 199] × 10(3)/mL, p = 0.03) but did not correlate with variations of microvascular reactivity. We observed no intravascular hemolysis (HbCO, heme, bilirubin, LDH), but recorded a significant increase in RBC microparticle levels specific to improving patients after transfusion (292 [108; 531] vs. 53 [34; 99] MP/μL; p = 0.03). The improvement in microvascular dilation was positively correlated with RBC microparticle levels (R = 0.83, p < 0.001) and conversion of arachidonic acid into vasodilating eicosanoids. CONCLUSIONS: Patients displaying an improved microvascular reactivity after RBC transfusion had high blood leukocyte counts, increased RBC microparticle formation, and enhanced metabolism of arachidonic acid into vasodilating lipids. Our data suggested a contribution of recipient leukocytes to the vascular impact of RBC transfusion. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13054-019-2572-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6717366 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-67173662019-09-06 Exploring the microvascular impact of red blood cell transfusion in intensive care unit patients Hariri, Geoffroy Bourcier, Simon Marjanovic, Zora Joffre, Jérémie Lemarié, Jérémie Lavillegrand, Jean-Rémi Charue, Dominique Duflot, Thomas Bigé, Naïke Baudel, Jean-Luc Maury, Eric Mohty, Mohamad Guidet, Bertrand Bellien, Jeremy Blanc-Brude, Olivier Ait-Oufella, Hafid Crit Care Research BACKGROUND: Red blood cell (RBC) transfusion is a common treatment for hospitalized patients. However, the effects of RBC transfusion on microvascular function remain controversial. METHODS: In a medical ICU in a tertiary teaching hospital, we prospectively included anemic patients requiring RBC transfusion. Skin microvascular reactivity was measured before and 30 min after RBC transfusion. Plasma was collected to analyze intravascular hemolysis and draw the lipidomic and cytokine profiles. RESULTS: In a cohort of 59 patients, the median age was 66 [55–81] years and SAPS II was 38 [24–48]. After RBC transfusion, endothelium-dependent microvascular reactivity improved in 35 (59%) patients, but worsened in 24 others (41%). Comparing clinical and biological markers revealed that baseline blood leucokyte counts distinguished improving from worsening patients (10.3 [5.7; 19.7] vs. 4.6 [2.1; 7.3] × 10(9)/L; p = 0.001) and correlated with variations of microvascular reactivity (r = 0.36, p = 0.005). Blood platelet count was also higher in improving patients (200 [97; 280] vs 160 [40; 199] × 10(3)/mL, p = 0.03) but did not correlate with variations of microvascular reactivity. We observed no intravascular hemolysis (HbCO, heme, bilirubin, LDH), but recorded a significant increase in RBC microparticle levels specific to improving patients after transfusion (292 [108; 531] vs. 53 [34; 99] MP/μL; p = 0.03). The improvement in microvascular dilation was positively correlated with RBC microparticle levels (R = 0.83, p < 0.001) and conversion of arachidonic acid into vasodilating eicosanoids. CONCLUSIONS: Patients displaying an improved microvascular reactivity after RBC transfusion had high blood leukocyte counts, increased RBC microparticle formation, and enhanced metabolism of arachidonic acid into vasodilating lipids. Our data suggested a contribution of recipient leukocytes to the vascular impact of RBC transfusion. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13054-019-2572-9) contains supplementary material, which is available to authorized users. BioMed Central 2019-08-30 /pmc/articles/PMC6717366/ /pubmed/31470888 http://dx.doi.org/10.1186/s13054-019-2572-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Hariri, Geoffroy Bourcier, Simon Marjanovic, Zora Joffre, Jérémie Lemarié, Jérémie Lavillegrand, Jean-Rémi Charue, Dominique Duflot, Thomas Bigé, Naïke Baudel, Jean-Luc Maury, Eric Mohty, Mohamad Guidet, Bertrand Bellien, Jeremy Blanc-Brude, Olivier Ait-Oufella, Hafid Exploring the microvascular impact of red blood cell transfusion in intensive care unit patients |
title | Exploring the microvascular impact of red blood cell transfusion in intensive care unit patients |
title_full | Exploring the microvascular impact of red blood cell transfusion in intensive care unit patients |
title_fullStr | Exploring the microvascular impact of red blood cell transfusion in intensive care unit patients |
title_full_unstemmed | Exploring the microvascular impact of red blood cell transfusion in intensive care unit patients |
title_short | Exploring the microvascular impact of red blood cell transfusion in intensive care unit patients |
title_sort | exploring the microvascular impact of red blood cell transfusion in intensive care unit patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717366/ https://www.ncbi.nlm.nih.gov/pubmed/31470888 http://dx.doi.org/10.1186/s13054-019-2572-9 |
work_keys_str_mv | AT haririgeoffroy exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients AT bourciersimon exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients AT marjanoviczora exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients AT joffrejeremie exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients AT lemariejeremie exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients AT lavillegrandjeanremi exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients AT charuedominique exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients AT duflotthomas exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients AT bigenaike exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients AT baudeljeanluc exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients AT mauryeric exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients AT mohtymohamad exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients AT guidetbertrand exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients AT bellienjeremy exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients AT blancbrudeolivier exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients AT aitoufellahafid exploringthemicrovascularimpactofredbloodcelltransfusioninintensivecareunitpatients |